Global personalized medicine market expected to generate revenue of around USD 3466 million by 2024, growing at a CAGR of around 11.9% between 2018 and 2024. Personalized medicines, also known as individualized medicines or precision medicines, is an evolving field used by physicians where diagnostic tests are performed to identify the biological markers.
Personalized Medicine Market
The report covers a forecast and an analysis for the personalized medicine market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes the drivers and restraints for the personalized medicine market along with the impact they have on the demand over the forecast period. Additionally, the report includes a study of opportunities available in the personalized medicine market on a global level.
In order to give the users of this report a comprehensive view on the personalized medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, where therapeutic area segment, application segment, technology segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the personalized medicine market by segmenting the market based on the therapeutic area, application, and technology, end-user, and region. All the segments have been analyzed based on present and future trends in the market are estimated from 2018 to 2024. Based on the therapeutic area, this market is segmented into oncology, neurology, cardiology, antiviral, psychiatry, and others. The key applications covered in this study include companion diagnostics, health informatics, biomarker identification, and clinical research. By technology, this market is segmented into pharmacogenomics, metabolomics, pharmacoproteomics, pharmacogenetics, stem cell therapy, pharmacodynamics, the point of care, and pharmacokinetics. By end-user, this market is segmented into hospitals, molecular diagnostic laboratories, and testing facilities, academic institutes, clinical care and research laboratories, contract research organization, bio and health informatics companies, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S., Canada, Germany, franc, UK, Brazil, China, Japan, India, and Brazil. This segmentation includes the demand for personalized medicine based on individual therapeutic areas and applications in all regions and countries.
The report also includes detailed profiles of various end players, such as F. Hoffmann-La Roche Ltd., Pfizer Inc., Qiagen, AstraZeneca Plc., Merck & Co., Inc., Siemens Healthcare GmbH, Vertex Pharmaceuticals Incorporated, and Becton, Dickinson, and Company, among others.
This report segments the global personalized medicine market as follows:
Global Personalized Medicine Market: Therapeutic Area Segment Analysis
Global Personalized Medicine Market: Application Segment Analysis
Global Personalized Medicine Market: Technology Segment Analysis
Global Personalized Medicine Market: End-User Segment Analysis
Global Personalized Medicine Market: Regional Segment Analysis